Comparison of conventional aggregomerty with VASP for monitoring P2Y12-specifc platelet inhibition

Author： Aradi Dániel Magyarlaki Tamás Tőkés-Füzesi Margit Rideg Orsolya Vorobcsuk András Komócsi András

ISSN： 1369-1635

Source： Platelets, Vol.21, Iss.7, 2010-11, pp. : 563-570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P2Y12 receptor in platelet activation

By Kim Soochong Kunapuli Satya P.

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 54-58

Informa Healthcare

Access to resources Recommend Favorite

Prostacyclin receptor stimulation facilitates detection of human platelet P2Y₁₂ receptor inhibition by the PFA-100® system

By Kobsar Anna L. Koessler Juergen Rajkovic Mirjana S. Brunner Kirsten P. Steigerwald Udo Walter Ulrich

Platelets, Vol. 21, Iss. 2, 2010-07 ,pp. : 112-116

Informa Healthcare

Access to resources Recommend Favorite

Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists

Current Vascular Pharmacology, Vol. 13, Iss. 5, 2015-01 ,pp. : 566-577

Bentham Science Publishers

Access to resources Recommend Favorite

The relative importance of the ADP receptors, P2Y 12 and P2Y 1 , in thrombin-induced platelet activation

By Nylander S. Mattsson C. Ramstrom S. Lindahl T.L.

Thrombosis Research, Vol. 111, Iss. 1, 2003-01 ,pp. : 65-73

Elsevier

Access to resources Recommend Favorite

Advances in the monitoring of anti-P2Y₁₂ therapy

By Harrison Paul

Platelets, Vol. 23, Iss. 7, 2012-11 ,pp. : 510-525

Informa Healthcare

Access to resources Recommend Favorite